Analysts foresee more revenue Gerresheimer

Tomorrow the German company Gerresheimer will publish its past quarter's results. Over the current book year the total revenue will be 1,37 billion euros (consensus estimates). This is slightly more than 2017's revenue of 1,35 billion euros.

Historical revenues and results Gerresheimer plus estimates 2018

The analysts expect for 2018 a net profit of 141 million euros. The majority of the analysts expects for this year a profit per share of 4,65 euros. So the price/earnings-ratio equals 14,44.

Per share the analysts expect a dividend of 1,22 euros per share. Thus the dividend yield equals 1,82 percent. The average dividend yield of the health care companies equals a low 1 percent.

Newest target prices around 67 euros

The most recent recommendations for the health care company are from Hauck & Aufhauser, Equinet-ag and JP Morgan.

Gerresheimer 's market capitalization is based on the number of outstanding shares around 2,11 billion euros. The Gerresheimer stock was the past 12 months quite unstable. Since last October the stock is 5 percent higher. This year the stock price moved between 61 and 80 euro. Since 2008 the stock price is almost 180 percent higher.

At 11.03 the stock trades 1,04 percent lower at 67,15 euros.

Price data Gerresheimer 2007-2018

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.